SOPHiA GENETICS' (SOPH) persistent losses, uncertain profitability, and cash concerns offset promising global expansion & ...

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today ...

Sophia Genetics acquires CDS software company. Genomics AI company Sophia Genetics has acquired Interactive Biosoftware, a maker of Alamut, a clinical decision support software for clinical genomic ...

Switzerland-based Sophia Genetics, a big data analytics company, raised $30 million in its latest round of funding, led by London-based Balderton Capital, according to Venture Beat.

Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer ...